Concept
Inhibitor.
- Web pages
- 96,562
- Websites
- 24,926
- Connected ideas
- 18,174
Counted from our sample of 72 million web pages.
In Brind's news
Events and explainers that mention inhibitor.Events
- Rise Therapeutics' candidate R-5780 enhances immune checkpoint inhibitor effectiveness and is the lead immuno-oncology candidate.Some support1 reportUpdated Sep 22
- Jubilant Therapeutics Inc. is advancing precision therapies, with its dual inhibitor JBI-802 showing activity in myeloproliferative neoplasms.Some support1 reportUpdated Sep 15
- Odyssey Therapeutics, Inc. is testing a RIPK2 inhibitor in clinical trials while also reporting on investor sentiment and financial results.Some support1 reportUpdated Sep 14
- BBO-8520, a drug candidate from BridgeBio Oncology Therapeutics, demonstrated a high response rate when combined with pembrolizumab. The compound functions as a KRASG12C inhibitor.Some support1 reportUpdated Sep 12
- Annexon, Inc. is seeking a BLA submission for neuroinflammatory disease and expects POC data for its oral C1 inhibitor.Some support1 reportUpdated Aug 12
- The FDA is reviewing applications for new medical treatments, including a C5 complement inhibitor for IgAN.Some support1 reportUpdated Aug 10
- Elanco Animal Health Incorporated and Inhibitor Therapeutics are being compared as healthcare companies.Some support1 reportUpdated Aug 6
- Processa Pharmaceuticals secured $200 million in private placement funding and added a clinical-stage BTK inhibitor pipeline via acquisition.Some support1 reportUpdated Jul 31
Kinds of inhibitor
Phrases that contain its name.Goes with
Ideas the web puts near inhibitor most often, strongest first. Tap one to step into it.- kinase 10,115 sites
- protease 6,592 sites
- aromatase 2,676 sites
- tyrosine 6,759 sites
- biological response 1,633 sites
- braf 1,591 sites
- cyclin dependent 1,060 sites
- androgen receptor 2,198 sites
- reuptake 4,698 sites
- selective estrogen 899 sites
- proton pump 3,186 sites
- proteasome 1,615 sites
- topoisomerase 1,106 sites
- mek 3,721 sites
- antitumor 3,457 sites
- glucocorticoid 2,476 sites
- estrogen receptor 2,550 sites
- bisphosphonate 776 sites
- receptor modulator 823 sites
- immunomodulator 732 sites
- stimulating hormone 2,107 sites
- pde5 2,129 sites
- antiemetic 1,265 sites
- gnrh 1,785 sites
- fusion protein 1,428 sites
- tumor infiltrating 849 sites
- protein 3 1,763 sites
- tils 644 sites
- radiopharmaceutical 1,413 sites
- idh 1,134 sites
How this page is made. The connections are counted from how millions of web pages place ideas near each other, then cleaned up by simple rules. They show what people connect, not what is true. The events and explainers come from Brind's own pages.